Long-term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years-Reference-Cited by-全球学者库

Long-term outcomes of entecavir monotherapy for chronic hepatitis B after liver transplantation: Results up to 8 years

Published:2017-08-26 Issue:4 Volume:66 Page:1036-1044
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Fung James¹²³^ORCID,Wong Tiffany¹⁴,Chok Kenneth¹⁴^ORCID,Chan Albert¹⁴,Cheung Tan-To¹⁴,Dai Jeff Wing-Chiu¹⁴,Sin Sui-ling¹⁴,Ma Ka-Wing¹⁴,Ng Kelvin¹⁴,Ng Kevin Tak-Pan⁴,Seto Wai-Kay²³^ORCID,Lai Ching-Lung²³,Yuen Man-Fung²³^ORCID,Lo Chung-Mau¹³⁴^ORCID

Affiliation:

1. The Liver Transplant Center; Queen Mary Hospital; Hong Kong

2. Division of Gastroenterology and Hepatology; Department of Medicine, The University of Hong Kong; Hong Kong

3. State Key Laboratory for Liver Research; The University of Hong Kong; Hong Kong

4. Division of Liver Transplantation; Department of Surgery, The University of Hong Kong; Hong Kong

Publisher

Wiley

Subject

Hepatology

Reference20 articles.

1. Management of chronic hepatitis B before and after liver transplantation;Fung;World J Hepatol,2015

2. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients;Samuel;Lancet,1991

3. Liver transplantation in European patients with the hepatitis B surface antigen;Samuel;N Engl J Med,1993

4. Long-term lamivudine therapy reduces the risk of long-term complications of chronic hepatitis B infection even in patients without advanced disease;Yuen;Antivir Ther,2007

5. Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis;Lo;Ann Surg,2001

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entecavir versus tenofovir on the recurrence of hepatitis B–related HCC after liver transplantation: A multicenter observational study;Liver Transplantation;2023-07-26

2. HBV prophylaxis after liver transplantation: close to the full success but at the price of long-term prophylaxis adapted to the risk of HBV recurrence;Hepatology International;2023-06-23

3. Early intrahepatic recurrence of HBV infection in liver transplant recipients despite antiviral prophylaxis;JHEP Reports;2023-06

4. The Role of Antiviral Prophylaxis in Preventing HBV and HDV Recurrence in the Setting of Liver Transplantation;Viruses;2023-04-23

5. Evaluation of HBsAg Seroclearance in Patients with Hepatitis B;Euroasian Journal of Hepato-Gastroenterology;2023-03-10